本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Neurosense Therapeutics Ltd

0.5108
+0.109227.19%
盤後0.4825-0.0283-5.54%19:58 EDT
成交量:422.41萬
成交額:193.42萬
市值:1,929.09萬
市盈率:-1.17
高:0.5257
開:0.4000
低:0.3600
收:0.4016
52周最高:1.98
52周最低:0.2500
股本:3,776.61萬
流通股本:2,584.64萬
量比:32.93
換手率:16.34%
股息:- -
股息率:- -
每股收益(TTM):-0.4366
每股收益(LYR):-0.4366
淨資產收益率:-2174.98%
總資產收益率:-247.30%
市淨率:-12.37
市盈率(LYR):-1.17

資料載入中...

2023/08/14

SEC問詢函

Form CORRESP - Correspondence
2023/07/21

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2023/04/05

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/03/22

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/03/15

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/03/15

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/03/15

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/01/26

SEC問詢函

CORRESP [Cover] - Correspondence
2022/04/14

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/02

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/12/30

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/12/23

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/12/20

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/12/06

SEC問詢函

CORRESP [Cover] - Correspondence
2021/12/06

SEC問詢函

CORRESP [Cover] - Correspondence
2021/12/06

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/12/06

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/11/19

SEC問詢函

CORRESP [Cover] - Correspondence
2021/11/19

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/11/10

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers